≡

Monoclonal Antibody to Matrix Metalloproteinase 14 (MMP14)

MMP-X1; MT1-MMP; MTMMP1; Membrane Inserted; Membrane-type matrix metalloproteinase 1; Membrane-type-1 matrix metalloproteinase

  • Product No.MAC056Hu22
  • Organism SpeciesHomo sapiens (Human) Same name, Different species.
  • SourceMonoclonal antibody preparation
  • HostMouse
  • Potency (Clone Number)n/a
  • Ig Isotype IgG
  • PurificationAntigen-specific affinity chromatography followed by Protein A affinity chromatography
  • LabelNone
  • Immunogen n/a
  • Buffer FormulationPBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
  • TraitsLiquid
  • Concentration1mg/mL
  • Organism Species Moren/a
  • ApplicationsWB; IHC; ICC; IP.
    If the antibody is used in flow cytometry, please check FCM antibodies.
  • Downloadn/a
  • UOM 20µl100µl 200µl 1ml 10ml
  • FOB US$ 111  US$ 259  US$ 370  US$ 925  US$ 3700 
    For more details, please contact local distributors!

SPECIFITY

The antibody is a mouse monoclonal antibody raised against MMP14. It has been selected for its ability to recognize MMP14 in immunohistochemical staining and western blotting.

USAGE

Western blotting: 0.2-2µg/mL;1:500-5000
Immunohistochemistry: 5-20µg/mL;1:50-200
Immunocytochemistry: 5-20µg/mL;1:50-200
Optimal working dilutions must be determined by end user.

STORAGE

Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Cancer Research Selective blockade of matrix metalloprotease-14 with a monoclonal antibody abrogates invasion, angiogenesis, and tumor growth in ovarian cancer Aacrjournals: Source
Anticancer Research Matrix metalloproteinase-2 and -14 in p16-Positive and -Negative HNSCC after Exposure To 5-FU and Docetaxel In Vitro Pubmed:25202075
Endocrine GLP-1 reduces metalloproteinase-14 and soluble endoglin induced by both hyperglycemia and hypoglycemia in type 1 diabetes PubMed: 25743265
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPC056Hu02 Recombinant Matrix Metalloproteinase 14 (MMP14) Positive Control; Immunogen; SDS-PAGE; WB.
RPC056Hu01 Recombinant Matrix Metalloproteinase 14 (MMP14) Positive Control; Immunogen; SDS-PAGE; WB.
PAC056Hu01 Polyclonal Antibody to Matrix Metalloproteinase 14 (MMP14) WB; IHC; ICC; IP.
PAC056Hu02 Polyclonal Antibody to Matrix Metalloproteinase 14 (MMP14) WB,IHC,ICC/IF
MAC056Hu22 Monoclonal Antibody to Matrix Metalloproteinase 14 (MMP14) WB; IHC; ICC; IP.
SEC056Hu ELISA Kit for Matrix Metalloproteinase 14 (MMP14) Enzyme-linked immunosorbent assay for Antigen Detection.
LMC056Hu Multiplex Assay Kit for Matrix Metalloproteinase 14 (MMP14) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.